Trial Profile
Entecavir in a Real-World setting
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Sep 2018
Price :
$35
*
At a glance
- Drugs Entecavir (Primary)
- Indications Hepatitis B
- Focus Adverse reactions; Therapeutic Use
- Acronyms ENUMERATE
- 20 Sep 2018 Results published in the Digestive Diseases and Sciences
- 28 Oct 2015 Results published in the Alimentary Pharmacology and Therapeutics
- 19 May 2015 Status changed from not stated to completed.